National Amphetamine-Type Stimulant Strategy Background Paper

More documents

Recommendations

Info

156 Bowers, J. & Johnson, S. (2003). Measuring the geographical displacement and diffusion of benefit effects of crime prevention activity. Journal of Quantitative Criminology, 19 (3), 275-301. Boys, A., Marsden, J., Griffiths, P., Fountain, J., Stilwell, G. & Strang, J. (1999). Substance uses among young people: The relationship between perceived functions and intentions. Addiction, 94 (7), 1042-1050. Bradbeer, T.M., Fleming, P.M., Charlton, P., & Crichton, J.S. (1998). Survey of amphetamine prescribing in England and Wales. Drug and Alcohol Review, 17, 299-304. Braga A. (2005). Hot spots policing and crime prevention: a systematic review of randomized controlled trials. Journal of Experimental Criminology, 1 (3), 317-342. Brauer, L.H. & De Wit, H. (1997). High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacology Biochemistry and Behavior, 56 (2), 265-272. Brookhuis, K.A.,de Waard, D., & Samyn, N. (2004). Effects of MDMA (ecstasy), and multiple drug use on (simulated) driving performance and traffic safety. Psychopharmacology, 173 (3-4), 440-445. Brown, P., Wise, R., & Kiyatkin, E. (2003). Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. Journal of Neuroscience, 23, 3924-3929. Burns, L., Mattick, R. & Cooke, M. (2006). Use of record linkage to examine illicit drug use in pregnancy. Addiction, 10 (6), 873-882. Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68, 299-307. Butler, T., Andrews, G., Allnutt, S., Sakashita, C., Smith, N.E., & Basson, J. (2006). Mental disorders in Australian prisoners: A comparison with a community sample. Australian and New Zealand Journal of Psychiatry, 40, 272-276. Buxton, N. & McConachie, N.S. (2000). Amphetamine abuse and intracranial haemorrhage. Journal of the Royal Society of Medicine, 93 (9), 472-477. Bywood, P., Pidd, K. & Roche, A. (2006). Information and Data Sheet 5: Illicit drugs in the Australian workforce: Prevalence and patterns of use, Workplace Drug and Alcohol Use Information and Data Series. Adelaide, South Australia: National Centre for Education and Training on Addiction, Flinders University. Caldicott, D.G.E., Beattie, R., & Edwards, J.W. (2005). Clandestine drug laboratories in Australia and the potential for harm. Australian and New Zealand Journal of Public Health, 29, 155- 162. Camilleri, A. M., & Caldicott, D. (2005). Underground pill testing, down under. Forensic Science International, 151(1), 53-58. Cantwell, B. & McBride, A.J. (1998). Self detoxification by amphetamine dependent patients: A pilot study. Drug and Alcohol Dependence, 49 (2), 157-163.
157 Carcach, C & Makkai, T, (2001). Review of Victoria Police Statistics, Research and Public Policy Series. Canberra: Australian Institute of Criminology. Carnwath, T., Garvey, T. & Holland, J.J. (2002). The prescription of dexamphetamine to patients with schizophrenia and amphetamine dependence. Journal of Psychopharmacology, 16(4), 373-377. Chaiken J., & Chaiken, M. (1990). Drugs and predatory crime. I M. Tonry & J. Wilson (Eds), Drugs and Crime. Chicago: University of Chicago Press. Chang, L., Cloak, C., Patterson, K. Grob, C., Miller, E.N. & Ernst, T. (2005). Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response. Biological Psychiatry, 57, 967-974. Chawla, S. (1998). ‘They’re synthetic. They’re clandestine. They can heal. They can kill.’ UN Chronicle, 25 (2), 34-36. Chen, C.K., Lin, S.K., Sham, P.C., Ball, S.D., Loh, E.W., Hsiao, C.C., Chiang, Y.L., Ree, S.C., Lee, C.H., & Murray, R.M. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33, 1407- 1414. Cherney, A., Juani O’Reilly, J., & Grabosky, P. (2006). The multilateralization of policing: The case of illicit synthetic drug control. Police Practice and Research, 7 (3), 17 -194. Chilvers, M., Korabelnikoff, V. & Ramsay, M. (2002). Recent trends in recorded crime and police activity in Cabramatta. Crime and Justice Bulletin, 7 May 2002. Cohen, R.S. (1998). The Love Drug: Marching to the Beat of Ecstasy. New York: Haworth Medical Press. Clemens, K.J., van Nieuwenhuyzen, P.S., Li, K.M., Cornish, J.L., Hunt, G.E., & McGregor, I.S. (2004). MDMA (“Ecstasy”), methamphetamine and their combination: Long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology, 173, 318-325. Clemens, K.J., McGregor, I.S., Hunt, G.E. & Cornish, J.L. (2007). MDMA, methamphetamine and their combination: Possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review, 26, 9-15. Collins, M., Dyer, K., & Fox, A. (unpublished). Neurocognitive profiles of amphetamine and alcohol dependent patients in an outpatient clinic. Conroy, A. (2006). An overview of mental health issues in a large community sample of amphetamine users in Queensland. Paper presented at the Australasian Amphetamines Conference; Sydney: Australia. Coupland, H., Ball, K., Costello, M., Harvey, B., & Maher, L. (2005). “Something is Going to Get Us: A Consultation and Development project for a National Campaign Addressing Injecting Drug Use in Indigenous Communities. AIVL.
Page 1:
National Amphetamine-Type Stimulant
Page 4 and 5:
ii Acknowledgments This research wo
Page 6 and 7:
iv Table of contents Acknowledgemen
Page 8 and 9:
vi List of tables Table 1.1: Amphet
Page 10 and 11:
viii
Page 12 and 13:
2 The NDS framework and the Law Enf
Page 14 and 15:
4 Table 1.1: Amphetamine-type stimu
Page 16 and 17:
6 particularly on the Pacific Coast
Page 18 and 19:
8 Figure 1.1: MDMA (ecstasy) tablet
Page 20 and 21:
10 a 10-year period. While some of
Page 22 and 23:
12 Figure 1.4: Forms of methampheta
Page 24 and 25:
14 Figure 1.5: Median purity of met
Page 26 and 27:
16 As noted, the route of administr
Page 28 and 29:
18 Chapter 2: Setting the Context T
Page 30 and 31:
20 Figure 2.2: Prevalence of ecstas
Page 32 and 33:
22 19 years (Dunn et al., 2007). Th
Page 34 and 35:
24 The use of MDMA among police det
Page 36 and 37:
26 this survey is conducted with th
Page 38 and 39:
28 models might be useful. On the o
Page 40 and 41:
30 the questionnaire in February 20
Page 42 and 43:
32 2.5 Summary According to the lat
Page 44 and 45:
34 anxiety, agitation, tremor, teet
Page 46 and 47:
36 may be stronger than the link wi
Page 48 and 49:
38 Srisurapanot and colleagues (200
Page 50 and 51:
40 Psychiatric problems appear to o
Page 52 and 53:
42 In 2005, there was a total of 68
Page 54 and 55:
44 The most recent EDRS survey foun
Page 56 and 57:
46 same reasons they use the drugs
Page 58 and 59:
48 Shoptaw and Reback (2007) review
Page 60 and 61:
50 It has also been speculated that
Page 62 and 63:
52 Parental ATS use In addition to
Page 64 and 65:
54 The Minnesota Department of Heal
Page 66 and 67:
56 Chapter 4: Prevention and Harm R
Page 68 and 69:
58 should cover the full range of d
Page 70 and 71:
60 specific drug (Spoth et al., 200
Page 72 and 73:
62 be applied regularly and systema
Page 74 and 75:
64 Strategies targeting vulnerable
Page 76 and 77:
66 Examples of particular periods t
Page 78 and 79:
68 At-risk workplaces There is incr
Page 80 and 81:
70 The consultation forum with Abor
Page 82 and 83:
72 young people was noted in the su
Page 84 and 85:
74 and/or others); mental health ef
Page 86 and 87:
76 of the fact that frequently peop
Page 88 and 89:
78 Sexual risk behaviour is a furth
Page 90 and 91:
80 • Cleaning up; • Transport o
Page 92 and 93:
82 Assessing the risks of illicitly
Page 94 and 95:
84 4.4 Challenges of applying preve
Page 96 and 97:
86 but a number of studies are now
Page 98 and 99:
88 The pack included a video, train
Page 100 and 101:
90 Chapter 5: Treatment and Service
Page 102 and 103:
92 to the occurrence of amphetamine
Page 104 and 105:
94 In relation to the need for spec
Page 106 and 107:
96 These studies replicate earlier
Page 108 and 109:
98 addressed not only the drug user
Page 110 and 111:
100 Research conducted in the subse
Page 112 and 113:
102 users, data that may be general
Page 114 and 115:
104 that limit brain exposure to me
Page 116 and 117: 106 only significant difference was
Page 118 and 119: 108 through the use of antipsychoti
Page 120 and 121: 110 to develop the capacity of the
Page 122 and 123: 112 It was also suggested that link
Page 124 and 125: 114 as new evidence emerges. New ps
Page 126 and 127: 116 border in 2000 (McKetin et al.,
Page 128 and 129: 118 Table 6.1: Number of clandestin
Page 130 and 131: 120 Table 6.2: Examples of domestic
Page 132 and 133: 122 Tasmania In 2004, strengthened
Page 134 and 135: 124 Recommendations from the consul
Page 136 and 137: 126 Although there are a number of
Page 138 and 139: 128 illegal drugs. When incarcerate
Page 140 and 141: 130 heroin) (Payne et al., 2007). I
Page 142 and 143: 132 Some examples of diversion prog
Page 144 and 145: 134 Other research has compared psy
Page 146 and 147: 136 Rehabilitation in Corrections T
Page 148 and 149: 138 Synthetic Drugs measure will im
Page 150 and 151: 140 • Stealing from motor vehicle
Page 152 and 153: 142 criminal offences There continu
Page 154 and 155: 144 • Increase international coll
Page 156 and 157: 146 • Ensuring offence and penalt
Page 158 and 159: 148 Law enforcement agencies are pl
Page 160 and 161: 150 Appendix 1 National consultatio
Page 162 and 163: 152 Appendix 2 Written submissions
Page 164 and 165: 154 Australian Institute of Health
Page 168 and 169: 158 Crits-Christoph, P., Siqueland,
Page 170 and 171: 160 Drug & Alcohol Services South A
Page 172 and 173: 162 Halkitis, P.N., Parsons, J.T.,
Page 174 and 175: 164 Hull, P., Rawstorne, P., Zablot
Page 176 and 177: 166 Leek, L., Seneque, D., & Ward,
Page 178 and 179: 168 McKetin, R., McLaren, J., Kelly
Page 180 and 181: 170 NSW Health (2006). Psychostimul
Page 182 and 183: 172 Ressler, K.J., & Nemeroff, C.B.
Page 184 and 185: 174 Small, W., Kerr, T., Charette,
Page 186 and 187: 176 United Nations Office for Drug
Page 188 and 189: 178
Page 190: 180
show all

National Amphetamine-Type Stimulant Strategy Background Paper

Create successful ePaper yourself

Delete template?

Save as template?